Home › Funds › BVF INC/IL › CGEM

BVF INC/IL position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

BVF INC/IL reported holding 5,750,683 shares of CGEM (CULLINAN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$104.7M, representing 2.68% of its reported portfolio and ranking #12 among its reported holdings. BVF INC/IL has disclosed CGEM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.75M sh
Reported value held$104.72M
Portfolio Weight2.68%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's CGEM position evolved

BVF INC/IL first disclosed a stake in CGEM in Q3 2023 at 3,196,701 shares (US$28.9M). The position peaked in Q2 2026 at 5,750,683 shares, worth US$104.7M. Across 12 filings, BVF INC/IL increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 5,750,683 shares valued at US$104.7M. Notable position changes include a 80% increase in Q2 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.20M $28.93M New
Q4 2023 3.20M $32.57M Hold
Q1 2024 3.20M $54.47M Hold
Q2 2024 5.75M $100.29M Add
Q3 2024 5.75M $96.27M Hold
Q4 2024 5.75M $70.04M Hold
Q1 2025 5.75M $43.53M Hold
Q2 2025 5.75M $43.30M Hold
Q3 2025 5.75M $34.10M Hold
Q4 2025 5.75M $59.52M Hold
Q1 2026 5.75M $81.72M Hold
Q2 2026 5.75M $104.72M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGEM and 13F data

CGEM (CULLINAN THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CGEM — the largest reported positions include MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), Kynam Capital Management, LP (US$56.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGEM

All CGEM fund holders →

FAQ

How long has BVF INC/IL held CGEM?

BVF INC/IL has disclosed CGEM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in CGEM?

As of Q2 2026, BVF INC/IL holds 5.75M shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $104.72M, representing 2.68% of its reported portfolio and ranking #12.

Has BVF INC/IL been buying or selling CGEM?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in CGEM. The position peaked in Q2 2026 at 5.75M shares.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, Kynam Capital Management, LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.